Standard Risk Acute Leukemia

Known as: Standard Risk, Standard Risk (MRD <0.05%) 
Acute leukemia patients are stratified into the standard risk group when their minimal residual disease levels are lower than 0.05%.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2018
012319842018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Donor killer immunoglobulin-like receptor (KIR) group B profiles (Bx) and homozygous of centromeric motif B (Cen-B/B) are the… (More)
Is this relevant?
2013
2013
UNLABELLED In childhood acute lymphoblastic leukemia (ALL) the reported 5-year event-free survival (EFS) rates are as high as 80… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2012
2012
BACKGROUND Children treated for acute lymphoblastic leukemia (ALL) as High Risk (HR) patients may be more vulnerable to… (More)
  • figure 1
  • table I
  • table II
  • table III
  • table IV
Is this relevant?
2012
2012
According to the published report on current practice of hematopoietic SCT in Europe, high-dose therapy (HDT) with autologous… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
The Children's Cancer Group enrolled 13 298 young people age <21 years on 1 of 16 protocols between 1983 and 2002. Outcomes were… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2010
2010
OBJECTIVES This retrospective study evaluates the role of pharmacogenomic determinants in the treatment of childhood acute… (More)
  • table I
  • table II
  • table III
  • figure 1
Is this relevant?
2008
2008
of its popularity, the execution of this technique often has flaws, among them are: Failing to differentiate between levels and… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium Protocol 91-01 was designed to improve the… (More)
Is this relevant?
2001
2001
Through inhibition of purine de novo synthesis and enhancement of 6-mercaptopurine (6MP) bioavailability high-dose methotrexate… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
1998
1998
Ataxia telangiectasia (A-T) is a rare autosomal recessive disorder characterized by cerebellar ataxia, oculocutaneous… (More)
Is this relevant?